WOONSOCKET – CVS Health Corp.’s preliminary prospectus for shareholders filed with the Securities and Exchange Commission Friday afternoon values its merger with Aetna Inc. at $69.7 billion, but the current share price of Aetna stock indicates skepticism in the future of the deal. As of Friday’s market closing, CVS stood at $82.01 per share with…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.